These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37271850)

  • 1. Management of patent foramen ovale in embolic stroke of undetermined source patients: Malaysian experts' consensus.
    Albart SA; Yusof Khan AHK; Wan Zaidi WA; Muthuppalaniappan AM; Kandavello G; Koh GT; Leong MC; Liew HB; Ong BH; Viswanathan S; Hoo FK; Looi I; Yap YG; Law WC
    Med J Malaysia; 2023 May; 78(3):389-403. PubMed ID: 37271850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
    Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipsilateral Carotid Plaque Presence is Inversely Associated with Patent Foramen Ovale in Cryptogenic Stroke: A Multicenter CohortStudy.
    Sathya A; Nguyen TN; Reyes-Esteves S; Kamen S; Hester T; Vigilante N; Woo J; Zhang L; Abdalkader M; Cucchiara B; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106606. PubMed ID: 35749935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
    Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
    J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of echocardiographic and clinical characteristics in embolic stroke and migraine patients with patent foramen ovale.
    Polat F; Kaya Z; Yaylak B; Onuk T
    Echocardiography; 2024 Feb; 41(2):e15770. PubMed ID: 38379240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A score of non-contrast transthoracic echocardiography to screen patent foramen ovale in patients with embolic stroke of undetermined source.
    Zhang H; Tang H; Wu F; Yu C; Dong Q; Cao W
    BMC Neurol; 2022 Feb; 22(1):43. PubMed ID: 35120481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R; Parreira L; Amador P; Silvestre I; Antunes C; Caria R
    J Echocardiogr; 2019 Mar; 17(1):44-51. PubMed ID: 30008156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
    Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
    Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closure of the patent foramen ovale in patients with embolic stroke of undetermined source: A clinical expert opinion and consensus statement for the Asian-Pacific region.
    Diener HC; Akagi T; Durongpisitkul K; Thomson VS; Prabhakar AT; Sharpe R; Albers B; Lewalter T; Oki K; Sharma VK
    Int J Stroke; 2020 Dec; 15(9):937-944. PubMed ID: 32677579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert consensus statement for the management of patients with embolic stroke of undetermined source and patent foramen ovale: A clinical guide by the working group for stroke of the Hellenic Society of Cardiology and the Hellenic Stroke Organization.
    Ntaios G; Tzikas A; Vavouranakis E; Nikas D; Katsimagklis G; Koroboki E; Manolis AS; Milionis H; Papadopoulos K; Sideris S; Spengos K; Toutouzas K; Tziakas D; Vassilopoulou S; Kanakakis I; Vemmos K; Tsioufis K
    Hellenic J Cardiol; 2020; 61(6):435-441. PubMed ID: 32135273
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
    Diener HC; Wachter R; Wong A; Thijs V; Schnabel RB; Ntaios G; Kasner S; Rothwell PM; Passman R; Saver JL; Albers BA; Bernstein RA
    Int J Stroke; 2023 Apr; 18(4):400-407. PubMed ID: 36050817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure in India; Feasibility, challenges and mid-term outcomes.
    Thomson VS; Aaron S; Samson D N; Krupa J; Prabhakar AT; Jose J; George P; George OK; Joseph G; Yadav BK
    Indian Heart J; 2021; 73(5):656-659. PubMed ID: 34627589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
    Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
    Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.